We’re altering immune cell metabolism to resolve disease. The field of immunometabolism is a rapidly emerging and exciting area of investigation into the role of intracellular metabolic pathways in immune cells.
Total raised: $39M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | Sofinnova ... | sofinnovap... |
| - | SV Health ... | svhealthin... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.09.2023 | - | $39M | - |
Mentions in press and media 10
| Date | Title | Description | Source |
| 08.03.2024 | On International Women's Day SV Venture Partner Ruth McKerna... | On International Women’s Day it is extremely pleasing to note the vast majority of SV Health Investo... | svhealthin... |
| 04.01.2024 | Sitryx announces collaboration partner Lilly has commenced a... | Oxford, UK – 4 January 2024 – Sitryx Therapeutics (“the Company”), a biopharmaceutical company focus... | svhealthin... |
| 20.12.2023 | Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia... | We've launched a new Fierce Biotech Fundraising Tracker for 2023 to track all the venture capital fl... | fiercebiot... |
| 27.09.2023 | Sitryx raises additional $39 million to progress development... | Oxford, UK – 27 September 2023 – Sitryx Therapeutics (“the Company”), a biopharmaceutical company fo... | svhealthin... |
| 27.09.2023 | Sitryx Therapeutics Raises $39M in Funding | Sitryx Therapeutics, an Oxford, UK-based biopharmaceutical company focused on regulating cell metabo... | finsmes.co... |
| 10.11.2021 | Sitryx appoints Tanya E. Borsuk, Ph.D., as Chief Business Of... | Oxford, UK – 10 November 2021 – Sitryx (“the Company”), a biopharmaceutical company focused on regul... | svhealthin... |
| 15.04.2021 | Sitryx further strengthens leadership team with the appointm... | Oxford, UK – 15 April 2021 – Sitryx (“the Company”), a biopharmaceutical company focused on regulati... | svhealthin... |
| 18.09.2020 | SV Health Investors welcomes six new Venture Partners to the... | Boston, MA & London, UK (September 18, 2020) – SV, a leading transatlantic healthcare venture ca... | svhealthin... |
| 31.03.2020 | SV Health Investors Announces Licensing and Research Collabo... | Boston, MA & London, UK (March 31, 2020) – SV Health Investors (SV), a leading transatlantic ven... | svhealthin... |
| 03.06.2019 | Oxford Startups to Watch: Healthtech, Edutech and More | 3 shares Share Tweet Pin LinkedIn Oxford’s outstanding academic reputation and support for inno... | techround.... |